• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
    • Examining Transportation
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • America at 250
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
    • Examining Transportation
  • Newsletters
More
    Advertisement
    Home › Tags › Posts tagged Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Pfizer stock trades halted over drug patent ruling Business

    Pfizer stock trades halted over drug patent ruling

    Linda Johnson · March 12, 2014 5:36 pm
    OxyContin maker to offer abuse-resistant Zohydro Business

    OxyContin maker to offer abuse-resistant Zohydro

    Matthew Perrone · March 12, 2014 4:13 pm
    Medical groups question price of new hep C drug Business

    Medical groups question price of new hep C drug

    Matthew Perrone · March 11, 2014 6:17 pm
    Sen. Joe Manchin seeks to block new painkiller Healthcare

    Sen. Joe Manchin seeks to block new painkiller

    Washington Examiner · March 10, 2014 6:32 pm
    Advertisement
    Endo gets US approval for long-acting testosterone Business

    Endo gets US approval for long-acting testosterone

    Matthew Perrone · March 6, 2014 5:14 pm
    Drug firms argue against $1.2B Arkansas judgment Business

    Drug firms argue against $1.2B Arkansas judgment

    Washington Examiner · February 27, 2014 4:59 pm
    FDA’s plan to ease drug shortages needs work Healthcare

    FDA’s plan to ease drug shortages needs work

    Peter Pitts · February 27, 2014 5:00 am
    Pfizer and Chesapeake are big market movers Business

    Pfizer and Chesapeake are big market movers

    Washington Examiner · February 24, 2014 9:39 pm
    Advertisement
    Endo Pharmaceuticals paying $172M False Claims Act settlement over Lidoderm patch

    Endo Pharmaceuticals paying $172M False Claims Act settlement over Lidoderm patch

    Jon Campisi · February 24, 2014 9:25 pm
    New York AG follows with settlement with Ranbaxy, Teva

    New York AG follows with settlement with Ranbaxy, Teva

    Bryan Cohen · February 21, 2014 8:53 pm
    Bayer clotting drug meets late-stage study’s goal Business

    Bayer clotting drug meets late-stage study’s goal

    Linda Johnson · February 18, 2014 11:12 pm
    Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B Business

    Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B

    Washington Examiner · February 18, 2014 12:04 pm
    Advertisement
    • ‹Previous page
    • 1
    • …
    • 133
    • 134
    • 135
    • 136
    • 137
    • ›Next page
    Page 135 of 137
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.